ACTIVE

CELforPharma

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

-21,3 k €

-156.5% YoY

Gross margin

149,7 k €

-36.0% YoY

Equity

323,2 k €

-6.2% YoY

Workforce

2,0 ETP

-20.0% YoY

What does CELforPharma do?

CELforPharma is a Private limited company incorporated in 2005. Its main activity is: Management consultancy activities. Its registered office is in Machelen (Brab.). It employs on average 2,0 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0871.088.704

Incorporation

07/01/2005

Legal form

Private limited company

Registered office

Jan Mommaertslaan 20 box a
1831 Machelen (Brab.) · FlandreSee on map

Contributed capital

20 000,00 €

Latest accounts

31/12/2025

Average workforce

2,0 ETP

Activities (NACE)

70200Management consultancy activities· main 70220Business and other management consultancy activities 74142Specialised design activities 74879Other professional, scientific and technical activities 82990Other business support service activities n.e.c.82990Other business support service activities n.e.c.+9

Joint committees (2)

Signals

Solid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	149,7 k €	-36.0%	233,9 k €	-5.8%	248,2 k €	-23.0%	322,5 k €	-70.4%	1,1 M €	+126%	480,7 k €	-43.1%	844,8 k €	+41.0%	599,1 k €	-7.4%	646,7 k €	+16.6%	554,5 k €	+18.4%	468,2 k €	-12.9%	537,7 k €	+70.6%	315,3 k €	+27.1%	248 k €	-8.5%	271,1 k €	+67.1%	162,2 k €	-3.2%	167,6 k €	+46.8%	114,2 k €	-19.2%	141,3 k €	+87.1%	75,5 k €
EBITDA	11,8 k €	-81.6%	64,4 k €	+360%	-24,7 k €	-133%	75 k €	-84.1%	472,6 k €	+815%	51,6 k €	-81.0%	271,3 k €	+94.0%	139,9 k €	-55.9%	317,2 k €	+66.6%	190,4 k €	+51.0%	126,1 k €	-59.1%	308,4 k €	+325%	72,6 k €	+256%	20,4 k €	-75.5%	83,3 k €	+430%	15,7 k €	-67.6%	48,5 k €	+7.4%	45,2 k €	-22.3%	58,2 k €	+90.0%	30,6 k €
Operating result	-10 k €	-123%	43,3 k €	+221%	-35,9 k €	-150%	72,2 k €	-84.6%	469,6 k €	+894%	47,2 k €	-81.6%	257,4 k €	+106%	125,1 k €	-57.4%	293,6 k €	+76.9%	166 k €	+60.6%	103,4 k €	-65.4%	298,3 k €	+362%	64,5 k €	+324%	15,2 k €	-80.8%	79,3 k €	+460%	14,2 k €	-68.9%	45,5 k €	+10.4%	41,2 k €	-23.5%	53,8 k €	+89.7%	28,4 k €
Net result	-21,3 k €	-157%	37,6 k €	+179%	-47,6 k €	-251%	31,5 k €	-90.5%	331 k €	+1806%	17,4 k €	-86.7%	130,9 k €	+126%	57,9 k €	-62.4%	154 k €	+87.0%	82,4 k €	+75.2%	47 k €	-70.9%	161,4 k €	+477%	28 k €	+787%	3,2 k €	-94.0%	53 k €	+822%	5,7 k €	-79.0%	27,3 k €	+6.6%	25,6 k €	-25.6%	34,4 k €	+122%	15,5 k €
Balance sheet
Equity	323,2 k €	-6.2%	344,5 k €	+12.2%	306,9 k €	-13.4%	354,5 k €	+0.4%	353 k €	-49.6%	700 k €	-17.1%	844 k €	+18.4%	713,1 k €	+8.8%	655,2 k €	+30.7%	501,2 k €	+19.7%	418,8 k €	+12.7%	371,8 k €	+76.7%	210,4 k €	+15.3%	182,4 k €	+1.8%	179,3 k €	+41.9%	126,3 k €	+4.8%	120,6 k €	+29.3%	93,3 k €	+37.8%	67,7 k €	+104%	33,2 k €
Total assets	619,9 k €	+7.7%	575,6 k €	+3.9%	553,7 k €	-20.8%	698,8 k €	-4.6%	732,6 k €	-33.6%	1,1 M €	-13.1%	1,3 M €	+8.7%	1,2 M €	+10.5%	1,1 M €	+35.1%	782,4 k €	+5.0%	744,9 k €	+8.8%	684,5 k €	+37.6%	497,5 k €	+42.5%	349,2 k €	-4.1%	364 k €	+38.1%	263,7 k €	+44.2%	182,9 k €	+4.2%	175,6 k €	-27.8%	243,1 k €	+162%	92,7 k €
Cash	191,3 k €	+43.9%	132,9 k €	-8.3%	144,9 k €	-40.0%	241,8 k €	+28.4%	188,2 k €	-67.2%	573,8 k €	-24.1%	755,9 k €	+24.7%	606,4 k €	+13.6%	533,9 k €	+64.7%	324,2 k €	-1.5%	329,2 k €	-18.7%	404,9 k €	+16.7%	346,8 k €	+32.3%	262,1 k €	-7.2%	282,4 k €	+36.9%	206,2 k €	+32.4%	155,8 k €	+9.9%	141,8 k €	+6.8%	132,8 k €	+67.3%	79,4 k €
Debts	83,5 k €	+13.9%	73,4 k €	-42.2%	126,8 k €	+14.4%	110,9 k €	-34.3%	168,9 k €	-19.5%	209,7 k €	-14.5%	245,2 k €	-33.4%	368 k €	+46.5%	251,1 k €	+11.3%	225,5 k €	+6.9%	211 k €	+28.2%	164,6 k €	+20.3%	136,9 k €	+9.9%	124,5 k €	+6.1%	117,3 k €	+29.0%	90,9 k €	+121%	41,1 k €	+52.2%	27 k €	-59.9%	67,3 k €	+18.1%	57 k €
Other
Workforce	2,0 ETP	-20.0%	2,5 ETP	-40.5%	4,2 ETP	-4.5%	4,4 ETP	-40.5%	7,4 ETP	+10.4%	6,7 ETP	+4.7%	6,4 ETP	+8.5%	5,9 ETP	+9.3%	5,4 ETP	-8.5%	5,9 ETP	-9.2%	6,5 ETP	+38.3%	4,7 ETP	+11.9%	4,2 ETP	+7.7%	3,9 ETP	+21.9%	3,2 ETP	+18.5%	2,7 ETP	+22.7%	2,2 ETP	+37.5%	1,6 ETP	+14.3%	1,4 ETP	+40.0%	1,0 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 9 ended

Active mandates

LAICO4Growth

Director · 0781.284.619

Represented by Annelies Swaan

Active

Ended mandates

LAICO4Growth

Director · since 14 février 2022 · 0781.284.619

Represented by Luc DE LANGHE

Ended

Luc De Langhe

Manager · since 01 septembre 2008 · 0899.716.669

Represented by Luc De Langhe

Ended

Luc De Langhe

Manager · since 01 septembre 2008 · 0899.716.669

Represented by LUC DE LANGHE

Ended

Luc De Langhe

Manager · since 07 janvier 2005 · until 01 septembre 2008

Ended

At this address

Other companies at this address

Company	CBE no.
CrediBill● Active	0809.178.750
Lincoln Transition Executive● Active	0553.872.869
SOLIS ENERGY● Active	1000.338.432
The Captains● Active	0743.651.983
VOCALCOM● Active	0422.504.680

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	03/06/2026	12/06/2025	05/06/2024	08/06/2023	20/07/2022	04/06/2021
General meeting	22/05/2026	23/05/2025	24/05/2024	26/05/2023	30/06/2022	28/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	22/05/2026	03/06/2026	Dutch	PDF
Abridged model	31/12/2024	23/05/2025	12/06/2025	Dutch	PDF
Abridged model	31/12/2023	24/05/2024	05/06/2024	Dutch	PDF
Abridged model	31/12/2022	26/05/2023	08/06/2023	Dutch	PDF
Abridged model	31/12/2021	30/06/2022	20/07/2022	Dutch	PDF
Abridged model	31/12/2020	28/05/2021	04/06/2021	Dutch	PDF
Abridged model	31/12/2019	31/07/2020	27/08/2020	Dutch	PDF
Abridged model	31/12/2018	24/05/2019	21/06/2019	Dutch	PDF
Abridged model	31/12/2017	25/05/2018	18/06/2018	Dutch	PDF
Abridged model	31/12/2016	26/05/2017	08/06/2017	Dutch	PDF
Abridged model	31/12/2015	27/05/2016	14/06/2016	Dutch	PDF
Abridged model	31/12/2014	22/05/2015	22/06/2015	Dutch	PDF
Abridged model	31/12/2013	23/05/2014	27/05/2014	Dutch	PDF
Abridged model	31/12/2012	24/05/2013	05/07/2013	Dutch	PDF
Abridged model	31/12/2011	25/05/2012	25/06/2012	Dutch	PDF
Abridged model	31/12/2010	27/05/2011	15/06/2011	Dutch	PDF
Abridged model	31/12/2009	28/05/2010	11/06/2010	Dutch	PDF
Abridged model	31/12/2008	22/05/2009	28/05/2009	Dutch	PDF
Abridged model	31/12/2007	23/05/2008	13/06/2008	Dutch	PDF
Abridged model	31/12/2006	25/05/2007	05/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 9 ended

Active mandates

LAICO4Growth

Director · 0781.284.619

Represented by Annelies Swaan

Active

Ended mandates

LAICO4Growth

Director · since 14 février 2022 · 0781.284.619

Represented by Luc DE LANGHE

Ended

Luc De Langhe

Manager · since 01 septembre 2008 · 0899.716.669

Represented by Luc De Langhe

Ended

Luc De Langhe

Manager · since 01 septembre 2008 · 0899.716.669

Represented by LUC DE LANGHE

Ended

Luc De Langhe

Manager · since 07 janvier 2005 · until 01 septembre 2008

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates09/07/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates18/02/2022
WIJZIGING RECHTSVORM - BENAMING - ONTSLAGEN - BENOEMINGEN
PDF
Other10/06/2015
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Registered office30/07/2013
MAATSCHAPPELIJKE ZETEL
PDF
Mandates09/01/2009
ONTSLAGEN - BENOEMINGEN
PDF
Other15/06/2006
BENAMING
PDF
Registered office20/02/2006
MAATSCHAPPELIJKE ZETEL
PDF
Other19/01/2005
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-21,3 k €↓
2024
Annual accounts 202437,6 k €↑
2023
Annual accounts 2023-47,6 k €↓
2022
Annual accounts 202231,5 k €↓
2021
Annual accounts 2021331 k €↑
2020
Annual accounts 202017,4 k €↓
2019
Annual accounts 2019130,9 k €↑
2018
Annual accounts 201857,9 k €↓
2017
Annual accounts 2017154 k €↑
2016
Annual accounts 201682,4 k €↑
2015
Annual accounts 201547 k €↓
2014
Annual accounts 2014161,4 k €↑
2013
Annual accounts 201328 k €↑
2012
Annual accounts 20123,2 k €↓
2011
Annual accounts 201153 k €↑
2010
Annual accounts 20105,7 k €↓
2009
Annual accounts 200927,3 k €↑
2008
Annual accounts 200825,6 k €↓
2007
Annual accounts 200734,4 k €↑
2006
Annual accounts 200615,5 k €
07/01/2005
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

CELforPharma

Overview

What does CELforPharma do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline